Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001437749-21-002502
Filing Date
2021-02-11
Accepted
2021-02-11 08:27:14
Documents
5

Document Format Files

Seq Description Document Type Size
1 FORM S-3/A navb20210210_s3a.htm S-3/A 125340
2 EXHIBIT 5.1 ex_225853.htm EX-5.1 23604
3 letterheadb.jpg GRAPHIC 4589
4 letterheadlogo01.jpg GRAPHIC 12962
5 letterheadlogo02.jpg GRAPHIC 12623
  Complete submission text file 0001437749-21-002502.txt   191970
Mailing Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017
Business Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

EIN.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-252847 | Film No.: 21616881
SIC: 2835 In Vitro & In Vivo Diagnostic Substances